Literature DB >> 19685294

Work disability in ankylosing spondylitis: differences among working and work-disabled patients.

Engin Cakar1, Mehmet Ali Taskaynatan, Umit Dincer, Mehmet Zeki Kiralp, Oguz Durmus, Ahmet Ozgül.   

Abstract

Ankylosing spondylitis (AS) is a systemic chronic inflammatory disease primarily affecting the axial skeleton. Work disability can be one of the major consequences of AS, and the knowledge about the burden of AS to the patient and society is not well-established yet. The objective of this study was to investigate work disability among patients with AS in the national service and to put forward the related factors and differences among disabled and nondisabled groups. A total of 121 male AS patients were included in the study. Patient demographics and duration of disease were noted, and employment status and disability were questioned. Measures of functionality, axial mobility, health-related quality of life, and depression were used. It was found that 38 patients (31.4%) continued their work lives with no change, 54 patients (44.6%) changed to a lighter job, and 29 patients (24%) were retired due to AS. Differences in age at onset of the disease, time since the diagnosis, C-reactive protein (CRP) levels, and hip involvement were statistically significant. The mean retirement age of the patients was 36 +/- 4.2 years. Frequency of hip involvement was higher in the work-disabled group. Spine was evidently affected more seriously, and CRP values were higher in the work-disabled group. Older age at onset, longer time since the diagnosis, longer diagnosis delay, and some physical impairments like decrease in spinal mobility and hip involvement may preclude AS patients from leading a productive work life.

Entities:  

Mesh:

Year:  2009        PMID: 19685294     DOI: 10.1007/s10067-009-1249-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities.

Authors:  Ron D Hays; Harlan Hahn; Grant Marshall
Journal:  Arch Phys Med Rehabil       Date:  2002-12       Impact factor: 3.966

2.  Employment perspectives of patients with ankylosing spondylitis.

Authors:  A M J Chorus; A Boonen; H S Miedema; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

3.  Work disability among people with ankylosing spondylitis.

Authors:  J H Barlow; C C Wright; B Williams; A Keat
Journal:  Arthritis Rheum       Date:  2001-10

4.  Risk factors for work disability in patients with ankylosing spondylitis.

Authors:  M M Ward; S Kuzis
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

5.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

6.  Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients.

Authors:  Ahmet Ozgül; Fatma Peker; M Ali Taskaynatan; A Kenan Tan; Kemal Dinçer; Tunç Alp Kalyon
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

7.  Impact of ankylosing spondylitis on work and family life: comparisons with the US population.

Authors:  Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2008-04-15

8.  Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status.

Authors:  Engin Cakar; Umit Dincer; Mehmet Zeki Kiralp; Mehmet Ali Taskaynatan; Evren Yasar; Emine Ozgur Bayman; Ahmet Ozgul; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-02-07       Impact factor: 2.980

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.

Authors:  Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

View more
  21 in total

1.  The effect of total hip replacement on employment in patients with ankylosing spondylitis.

Authors:  Chongru He; Xiaokang He; Wenwen Tong; Wei Zheng; Tianfang Zhang; Jinzhu Zhao; Weidong Xu
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

2.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 9 International classification of functioning, disability and health (ICF)].

Authors:  U Kiltz; W Mau; U Repschläger; E Böhle; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

3.  Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors.

Authors:  Semra Yigit; Zerrin Sahin; Saliha Eroglu Demir; Deniz Hatun Aytac
Journal:  Rheumatol Int       Date:  2012-01-05       Impact factor: 2.631

4.  The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility.

Authors:  Chun-Hsiung Chen; Hung-An Chen; Hsien-Tzung Liao; Chin-Hsiu Liu; Chang-Youh Tsai; Chung-Tei Chou
Journal:  Rheumatol Int       Date:  2015-02-24       Impact factor: 2.631

5.  [Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Authors:  U Kiltz; J Braun; A Becker; J-F Chenot; M Dreimann; L Hammel; A Heiligenhaus; K-G Hermann; R Klett; D Krause; K-F Kreitner; U Lange; A Lauterbach; W Mau; R Mössner; U Oberschelp; S Philipp; U Pleyer; M Rudwaleit; E Schneider; T L Schulte; J Sieper; A Stallmach; B Swoboda; M Winking
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

6.  Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a phase III study.

Authors:  Désirée van der Heijde; Jürgen Braun; Martin Rudwaleit; Oana Purcaru; Arthur F Kavanaugh
Journal:  RMD Open       Date:  2018-04-09

Review 7.  Patient Burden of Axial Spondyloarthritis.

Authors:  Vibeke Strand; Jasvinder A Singh
Journal:  J Clin Rheumatol       Date:  2017-10       Impact factor: 3.517

Review 8.  Work Disability in Axial Spondyloarthritis.

Authors:  Elena Nikiphorou; Sofia Ramiro
Journal:  Curr Rheumatol Rep       Date:  2020-07-27       Impact factor: 4.592

9.  Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Authors:  Ruxandra Schiotis; Nerea Bartolomé; Alejandra Sánchez; Magdalena Szczypiorska; Jesús Sanz; Eduardo Cuende; Eduardo Collantes Estevez; Antonio Martínez; Diego Tejedor; Marta Artieda; Anca Buzoianu; Juan Mulero
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

Review 10.  Concurrent Intervention With Exercises and Stabilized Tumor Necrosis Factor Inhibitor Therapy Reduced the Disease Activity in Patients With Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Hui Liang; Wen-Rong Li; Hua Zhang; Xu Tian; Wei Wei; Chun-Mei Wang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.